Descartes’ Study Finds 67% of Freight Forwarders and Customs Brokers View Technology as Fundamental to Growth
Intuitive doubles down on AI with the launch of Intuitive.ai powered by aiE™ framework to build the future of intelligent enterprisesÂ
Dash Social Unveils the Total Social Impact Score: The New Standard for Brands to Measure Their Social Footprint
Franklin Wireless Begins Shipping its first 5G Fixed Wireless Router Built for Resilient Connectivity Across Communities and Networks
From Hong Kong Airport to Hengqin: Chimelong Ferry Sets Sail for a Worry-Free Journey
~ Presentation to highlight the potential of Gennao’s proprietary, non-viral gene monoclonal antibody (GMAB) platform…
PALO ALTO, Calif., March 10, 2021 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL),…
MONTREAL, March 10, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a…
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical…
Tumor model data shows potential of CCR4 antagonist to alter immunosuppressive tumor microenvironment to improve…
RLY-4008 demonstrates strong activity against known clinical on-target resistance mutations in cellular and in vivo…
Additional preclinical data on ZN-c3 and the Company’s EGFR inhibitor, ZN-e4, will be presented as…
FARMINGTON HILLS, Mich., March 10, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
NEW HAVEN, Conn., March 10, 2021 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage…
SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics…
Provided positive update on its four TriTAC® clinical trials, including a confirmed partial response for…
Conference Call and Webcast at 5:00 pm Eastern Time THE WOODLANDS, Texas, March 10, 2021…
– Preparations for potential launch of first Endocrinology Rare Disease product candidate, TransCon hGH (lonapegsomatropin),…
– OASIS Wet AMD Phase 1/2a Trial Initiated and Cohort 1 Dosing Completed – –…
DEINOVE benefits from the support of the French government, within the framework of the “France…
VANCOUVER, British Columbia, March 10, 2021 (GLOBE NEWSWIRE) — Segra International Corp. and Allele Genetics,…
– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance…